Skip to main content

Have dopamine, will travel

Inhibitory neurons make up about a third of the neurons in the cerebral cortex, but researchers know little about how they take their place in the developing brain. New findings suggest that their migration is controlled by a back and forth interplay between a pair of dopamine receptors, modulated by several other molecules, researchers said today (November 18) at the linkurl:annual meeting of the Society for Neuroscience.;https://www.sfn.org/am2008/ Neurons that respond to GABA, the main inhibi

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Inhibitory neurons make up about a third of the neurons in the cerebral cortex, but researchers know little about how they take their place in the developing brain. New findings suggest that their migration is controlled by a back and forth interplay between a pair of dopamine receptors, modulated by several other molecules, researchers said today (November 18) at the linkurl:annual meeting of the Society for Neuroscience.;https://www.sfn.org/am2008/ Neurons that respond to GABA, the main inhibitory neurotransmitter in the brain, regulate cell proliferation and the formation of proper neural circuitry. Several developmental disorders including epilepsy and autism involve malfunctioning GABA neurons. Last year, Harvard Medical School researcher linkurl:Pradeep Bhide;https://www.massgeneral.org/children/research/researchers/bhide.aspx and colleagues showed in brain slices of mouse brains and in knockout mouse that activating the dopamine-1(D-1) receptor led to increased migration of GABA neurons, while activating the dopamine-2 (D-2) receptor decreased the movement of GABA neurons. "It is interesting that even in the embryonic brain, D-1 and D-2 produce opposite effects," Bhide said in his talk today. More recently, Bhide's team exposed fetal mice to cocaine --which is known to disrupt dopamine transport -- and found that the homeobox transcription factor gene NKX2-1 also inhibits GABA migration. Whether NXK2-1 and the D-2 receptor interact directly is still unknown, although Bhide hypothesizes that cocaine, which upregulates the expression of NXK2-1, may be acting to alter dopamine levels, which in turn boosts D-2 receptor function Bhide's team has also begun to look at other molecular players, such as the protein TorsinA, which is underexpressed in the developmental disorder Tortia Dystonia. Tortia Dystonia, a movement disorder that leads to the loss of motor control, also happens to be associated with a dopamine imbalance during early development. In culture slice and knock-out experiments, Bhide's team showed that the loss of TorsinA decreases overall neuronal migration. His studies didn't identify a mechanism, but research in fibroblasts has shown that a drop in TorsinA boosts D-2 receptor and NKX21 activity -- both of which decrease GABA migration. Bhide believes that TorsinA, like cocaine, somehow acts on the D-2 receptor by altering dopamine levels. The details remain to be worked out, but what?s certain is that an imbalance of dopamine levels in the brain can drastically alter development, he said.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
From Pilot to Practice: Advancing Regulatory Reliance

From Pilot to Precedent: A Year of Regulatory Innovation through PRISM and What it Means for Cloud Adoption in Regulatory Submissions

DNAnexus
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation